ReviewCureus2026
Clinical Outcomes of Platelet-Rich Plasma in Otology: A Systematic Review of Tympanoplasty, Myringoplasty, and Hearing Loss Management.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Platelet-rich plasma (PRP), an autologous concentrate of platelets and growth factors, has been explored as an adjunct in otologic procedures, including tympanoplasty, myringoplasty, and treatment of sudden sensorineural hearing loss (SNHL). This systematic review evaluated reported clinical outcomes associated with PRP in these settings. A literature search was conducted in March 2025 across PubMed, Scopus, Web of Science, EMBASE, and the Cochrane Library. Eligible studies were English-language human studies (2015-2025) with original clinical outcome data from randomized or comparative observational designs. Due to methodological heterogeneity, findings were synthesized narratively. Six studies (n = 349 patients) were included: five addressing tympanic membrane repair and one addressing idiopathic sudden SNHL. In myringoplasty/tympanoplasty-related studies, PRP was generally associated with higher graft uptake and/or faster healing than comparator approaches; where reported, closure outcomes included 85.7% versus 60% in one comparative study, and several studies reported between-group differences with p < 0.05. Reported postoperative complications were low, and no major PRP-related safety concerns were identified in the included studies. In SNHL, one comparative study suggested hearing improvement with intratympanic PRP that was comparable to, or greater than, steroid therapy, but evidence remains limited to short-term follow-up and a small number of studies. Current evidence supports PRP as a feasible and apparently safe adjunct in otologic practice, particularly for tympanic membrane repair. However, certainty regarding the magnitude of benefit and long-term auditory outcomes remains limited by small sample sizes, heterogeneity in PRP preparation/application, and variability in study design. Standardized protocols and larger, well-designed randomized trials are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.